Navigation For Mobile

Category Archives: Pharm Tech

Solving the Insoluble

Soluble drug APIs are now the exception, not the rule. An article at PharmTech by Felicity Thomas (Looking Beyond the Solubility Horizon) caught my eye recently as it discussed a…

Posted in APIs, Capabilities, Chemistry, Contract Manufacturing, CRO/CMO, Pharm Tech, Pharmaceutical Technology, R&D, Route Design, Route Scouting, synthesis | Tagged , , , , | Comments Off on Solving the Insoluble

November: Catching Up on Pharma Articles

This month, I managed to catch up on some of the industry articles I’ve been waiting to read which were relevant to APIs and pharma manufacturing generally. Here are a…

Posted in APIs, Contract Manufacturing, drugs, Industry news, Pharm Tech, Pharmaceutical Technology, science education | Comments Off on November: Catching Up on Pharma Articles

Continuous Improvement in Drug Manufacturing – Still a Ways to Go

The healthcare industry is driven by scientific innovation, often in response to various public health crises. But while science & discovery often leap forward, the physical act of manufacturing a…

Posted in continuous manufacturing, Pharm Tech, Pharmaceutical Technology, process chemistry | Comments Off on Continuous Improvement in Drug Manufacturing – Still a Ways to Go

Defining the Relationship Between the Pharma Industry & Regulatory Agencies

I read an article at PharmTech at the tail end of 2016 that I thought was quite interesting, and it reflects Neuland’s position on regulatory agencies & issues. The article…

Posted in Contract Manufacturing, CRO/CMO, drugs, FDA, Neuland Labs, Pharm Tech, Pharmaceutical Technology, Quality, regulatory | Comments Off on Defining the Relationship Between the Pharma Industry & Regulatory Agencies

Niche Growth & Growing Niches: A Market Report on APIs and Eroom’s Law

A recent market report on APIs by Future Market Insights (FMI) paints a generally rosy economic picture of the industry over the next decade, but in this case the report’s…

Posted in API synthesis, APIs, Contract Manufacturing, drug discovery, drugs, Neuland Labs, peptide, peptides, Pharm Tech, Pharmaceutical Technology | Comments Off on Niche Growth & Growing Niches: A Market Report on APIs and Eroom’s Law

Moving Towards Specialty APIs

In a recent issue of PharmTech, Agnes Shanley wrote an article on the specialty markets and services driving the growth of APIs in which we were featured. For me, the…

Posted in API synthesis, Capabilities, Chemistry, CMC, Contract Manufacturing, CRO/CMO, Neuland Labs, outsourcing, Pharm Tech, Pharmaceutical Technology, QbD, Quality | Comments Off on Moving Towards Specialty APIs

Pharmaceutical API Contract Manufacturing: Reading Room

I’ve been trying to get caught up on some reading this month, and thought I’d put together a roundup of interesting articles I’ve run across recently. Grading GDUFA, at Contract…

Posted in analytical science, API synthesis, APIs, Chemistry, CMC, Contract Manufacturing, CRO/CMO, GDUFA, green chemistry, Pharm Tech, Pharmaceutical Technology, process chemistry | Comments Off on Pharmaceutical API Contract Manufacturing: Reading Room

APIs See Continuous Improvement…but Only Until Clinical Trials

In what can best be described as a quality paradox, continuous process improvement has become something of a buzzword in the pharma manufacturing industry. But, as Epcot President & CPhI…

Posted in continuous manufacturing, genotoxic impurities, Pharm Tech, regulatory | Comments Off on APIs See Continuous Improvement…but Only Until Clinical Trials

APIs – Continued Growth, Increasing Complexity

I was interviewed back in April for a Pharmaceutical Technology (PharmTech) article about demand drivers for small-molecule APIs. The article by Agnes Shanley – Pharma APIs:  It’s Still a Small…

Posted in API synthesis, APIs, Pharm Tech, Pharmaceutical Technology, QbD, small molecule | Comments Off on APIs – Continued Growth, Increasing Complexity

Investigation of Various Impurities in Febuxostat

In this month’s issue of PharmTech, team members at Neuland’s R&D Center in Hyderabad published a peer-reviewed article on the analysis and management of impurities in the drug Febuxostat. Febuxostat, a…

Posted in analytical science, Capabilities, Chemistry, drugs, Febuxostat, method development, Neuland Labs, peer-review, Pharm Tech, Pharmaceutical Technology, QA/QC, regulatory | Comments Off on Investigation of Various Impurities in Febuxostat